Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
TROD MEDICAL from Zaventem, company number BE0536848874, closed financial year 2025 with a result of € -5,338 after tax. For that financial year TROD MEDICAL recorded a gross margin of € -5,040 and equity of € -103,444. Compared with financial year 2024, the result moved from € -7,326 to € -5,338. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ -103,444
▼ € 5,338 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5,338
▲ 27 % less loss than in 2024
Profit after tax over the fiscal year.
€ 43,929
▼ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -14.1 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 116,588
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 436,533 | € -2,358 | € -6,801 | € -5,040 | ▲ € 1,761 |
| Profit after taxes | € 66,629 | € -75,989 | € -7,326 | € -5,338 | ▲ € 1,988 |
| Equity | € -14,790 | € -90,779 | € -98,105 | € -103,444 | ▼ € 5,338 |
| Total debts | € 371,707 | € 371,589 | € 371,105 | € 370,836 | |
| Cash | € 57,578 | € 58,975 | € 51,127 | € 43,929 | ▼ 14% |
| Retained profit | € -14,039,845 | € -14,115,833 | € -14,123,160 | € -14,128,498 | |
| Balance sheet total | € 356,917 | € 280,811 | € 273,000 | € 267,393 | ▼ 2% |
Key figures of TROD MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to TROD MEDICAL?
What happened at TROD MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 5,338. Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Zaventem. KBO
In short
From € 66,629 profit in 2022 to € 5,338 loss in 2025.
Paid € 25 in corporate taxes since 2022.
Best year ever: 2022, with € 66,629 profit.
Management
The stake of Vesalius Biocapital II ARKIV comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
TROD MEDICALBehind TROD MEDICAL are Paul Birkmeyer, Michael Brock, Stephan Verdood and Christian Schneider. The shares are held by Vesalius Biocapital II ARKIV (22.9%).
Directors
According to the 2025 annual accounts
Paul Birkmeyer
Managing director
Michael Brock
Director
Christian Schneider
Director
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lenneke Marelaan 8
1932 Zaventem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →GRUNENTHAL
€ 39.3 million revenue · 2025
Belgian Recorded Music Association
SIMIM Société de l'Industrie Musicale - Muziekindustrie Maatschappij
IMAGIA
ALMA COURT INVEST
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0536.848.874
- VAT number
- BE 0536.848.874
- Registered office
- Lenneke Marelaan 8, 1932 Zaventem
- Names & denominations
- TROD MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 July 2013
- Peppol
- Active · Active since 1 Jan 2001